2018 Neurotech Leaders Forum

October 15-16, 2018

Embassy Suites, San Francisco Airport Waterfront

Tentative Agenda

Day One

8:00-8:30

Registration and Coffee

8:30-9:15

State of the Neurotechnology Industry: 2018

James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto provides his insights and observations on the state of the neurotechnology industry. He surveys changes in the competitive landscape that have occured over the years, the most significant events of the last year, and challenges confronting the industry in years ahead.
9:15-10:00

Keynote Address

P. Hunter Peckham, Ph.D., Founder, Institute for Functional Restoration
10:00-10:30

Refreshment Break

10:30-11:15

Preparing for Exit: Neurotech Funding Alternatives

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Imran Eba, Partner, Action Potential Venture Capital
Neurotech startups have access to a variety of equity and non-dilutive financing options. In this panel, we'll address some of the key decisions that entrepreneurs must confront when planning their long-term strategy.
11:15-12:00

Sharing the Pain: What the Opioid Crisis Means for Neuromodulation

James Cavuoto, Editor, Neurotech Reports, Moderator
The opioid crisis has created new opportunitites for pain neuromodulation device vendors, and the U.S. government has just set aside $500 million to address the problem. In this session, we'll discuss how the industry can best serve the healthcare system and how to handle the hurdles still facing suppliers of non-pharmaceutical therapies.
12:00-1:30

Luncheon, Sponsored by Cirtec Medical

Neurotech Reports Staff Introductions
1:30-3:00

Neurotechnology Entrepreneur Panel

James Cavuoto, Editor, Neurotech Reports, Moderator
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets.
3:00-3:30

Refreshment Break

3:30-4:15

Spreading the News: Effective Targeting of Neurotech's Message

Jennifer French, Senior Editor, Neurotech Reports, Moderator
As neurotechnology gains traction in the media, neurotech vendors will want to develop an effective marketing communications strategy. In this session, we'll highlight examples of successful and unsuccessful PR campaigns and we'll explore the intracacies of refinfing messaging for consumer and professional audiences.
4:15-5:00

Paying the Piper: New Directions in Pricing and Reimbursement

Jeremy Koff, Senior Contributing Editor, Neurotech Reports, Moderator
Several pioneering neurotechnology firms have introduced new pricing and revenue models that could fundamentally alter the way neurotech devices are financed. In this session, we'll discuss examples of per-dose neuromodulation pricing, as well as novel strategies for obtaining reimbursement from private and government payers.
5:00-7:00

Cocktail Reception, Sponsored by MST

 
 

 

Day Two

8:00:8:30

Registration and Coffee

8:30-8:45

Standing Out from the Crowd: Neuromodulation Gets Competitive

James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Reports editor James Cavuoto provides his insight on the new competitive landscape within the neuromodulation industry. He'll provide an overview of the players battling for market share in markets like SCS, DBS, SNS, TMS, neuroprosthetics, neurorobotics, and others.
8:45-9:15

Keynote Address

 
9:15-10:00

Regulatory Update: The U.S. vs. Overseas

Jeremy Koff, Senior Contributing Editor, Neurotech Reports, Moderator
Regulatory changes in Europe and other regions may swing the pendulum back toward the U.S. in terms of getting new neurotech products to market. In this session, we'll look at recent trends in FDA approval of new devices vis a vis in international markets.
10:00-10:30

Coffee Break

10:30-11:15

Fixing Brain and Body: Advances in Neurorehabilitation and Cortical Stimulation

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Brain stimulation--both noninvasive and implanted--has become a powerful tool for fostering recovery from neurological disorders such as stroke, TBI, and others. In this session, we'll look at several examples of promising therapies for both neuromuscular and cognitive disorders.
11:15-12:00

Going Bioelectronic: The Coming Merger of Neuromodulation and Bioelectronic Medicine

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Imran Eba, Partner, Action Potential Venture Capital
Chris Czura, Ph.D., Vice President, Feinstein Institute for Medical Research
As the new field of bioelectronic medicine has emerged, it has raised questions about where it fits within the neuromodulation industry. In this session, we'll explore the boundaries of both fields and discuss the opportunities for recruiting staff, technology, and infrastructure from the biopharmaceutical industry.
12:00-1:30

Luncheon, Sponsored by Cirtec Medical

Presentation of 2018 Gold Electrode Awards
1:30-3:00

Neurotechnology Entrepreneur Panel

James Cavuoto, Editor, Neurotech Reports, Moderator
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets.
3:00-3:30

Refreshment Break

3:30-4:15

Neurotech's Farm System: Nurturing the Next Generation of Devices and Therapies

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Most of the neurotechnology products on the market today began life in a university or private research laboratory. In this session, we'll look at some of the leading neurotechnology research institutions and examine the role that technology transfer offices can play in commercializing new products.
4:15-5:00

Brain Barriers: Exploring the Limits of Brain Stimulation and Sensing

James Cavuoto, Editor, Neurotech Reports, Moderator
Advances in technologies such as deep-brain-stimuation. EEG sensing, and brain-computer interfaces have made possible a new generation of clinical and consumer products. In this closing session, we'll explore the technological and ethical boundaries of brain interfacing. And we'll debate what limits should be placed on product development and distribution.
5:00-7:00

Cocktail Reception, Sponsored by MST

 
 

 

site design by shalatdesign | shalat.com